Evidence map›Paper›PMID 37301774›Full record

ArticleEuropean archives of psychiatry and clinical neuroscience2023

Schizophrenia polygenic risk score in psychosis proneness.

Patricia Mas-Bermejo, Sergi Papiol, Marc Via, Paula Rovira, Pilar Torrecilla, Thomas R Kwapil, Neus Barrantes-Vidal, Araceli Rosa

Open access · hybridAbstract read
In one paragraph

Article in European archives of psychiatry and clinical neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Patricia Mas-Bermejo *Secció de Zoologia i Antropologia Biològica. Departament de Biologia Evolutiva, Ecologia i Ciències Ambientals. Facultat de Biologia, Universitat de Barcelona, Avda. Diagonal 643, 08028, Barcelona, Spain.ORCID http://orcid.org/0000-0003-4789-9650
Sergi Papiol *Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, 80336, Munich, Germany.ORCID http://orcid.org/0000-0001-9366-8728
Marc ViaBrainlab, Cognitive Neuroscience Research Group, Department of Clinical Psychology and Psychobiology, Universitat de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-9966-9921
Paula RoviraVicerectorat de Recerca, Investigadora Postdoctoral Margarita Salas, Universitat de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0003-2177-8412
Pilar TorrecillaDepartment of Clinical and Health Psychology, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0003-2017-6014
Thomas R KwapilDepartment of Psychology, University of Illinois at Urbana-Champaign, Champaign, IL, USA.ORCID http://orcid.org/0000-0003-1116-5954
Neus Barrantes-VidalCIBER de Salud Mental, Instituto de Salud Carlos III, Madrid, Spain.ORCID http://orcid.org/0000-0002-8671-1238
Araceli RosaSecció de Zoologia i Antropologia Biològica. Departament de Biologia Evolutiva, Ecologia i Ciències Ambientals. Facultat de Biologia, Universitat de Barcelona, Avda. Diagonal 643, 08028, Barcelona, Spain. araceli.rosa@ub.edu.ORCID http://orcid.org/0000-0001-6935-3785
Instituto de Salud Carlos III · ESUniversitat Autònoma de Barcelona · ESInstitut de Biomedicina de la Universitat de BarcelonaSant Joan de Déu Research Foundation · ESUniversidad de Granada · ESUniversity of Illinois Urbana-Champaign · US

Funding

Departament de Salut, Generalitat de Catalunya 2021SGR00706Departament de Salut, Generalitat de Catalunya 2021SGR01010Ministerio de Economía y Competitividad 02-RMinisterio de Economía y Competitividad PID2020-119211RB-I00Ministerio de Economía y Competitividad PSI2017-87512-C2-01
6 · The paper itself

Abstract

Schizophrenia (SZ) is a complex disorder with a highly polygenic inheritance. It can be conceived as the extreme expression of a continuum of traits that are present in the general population often broadly referred to as schizotypy. However, it is still poorly understood how these traits overlap genetically with the disorder. We investigated whether polygenic risk for SZ is associated with these disorder-related phenotypes (schizotypy, psychotic-like experiences, and subclinical psychopathology) in a sample of 253 non-clinically identified participants. Polygenic risk scores (PRSs) were constructed based on the latest SZ genome-wide association study using the PRS-CS method. Their association with self-report and interview measures of SZ-related traits was tested. No association with either schizotypy or psychotic-like experiences was found. However, we identified a significant association with the Motor Change subscale of the Comprehensive Assessment of At-Risk Mental States (CAARMS) interview. Our results indicate that the genetic overlap of SZ with schizotypy and psychotic-like experiences is less robust than previously hypothesized. The relationship between high PRS for SZ and motor abnormalities could reflect neurodevelopmental processes associated with psychosis proneness and SZ.

Indexed as

Psychotic DisordersSchizophreniaGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMultifactorial InheritanceGenetic overlapMotor abnormalitiesPolygenic risk scorePsychotic-like experiencesSchizophreniaSchizotypy

Identifiers

PMID37301774
PMCPMC10713704
OpenAlexW4380148567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.